memo—new frontiers to be reached Wolfgang HilbeWaltraud Radlherr editorial 08 March 2016 Pages: 57 - 58
Intravascular large B‑cell lymphoma Silvia HoferManfred KesslerStefan Aebi case report 03 May 2016 Pages: 59 - 62
Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option Jan-Paul BohnGuenther GastlMichael Steurer case report Open access 17 June 2016 Pages: 63 - 65
Immunotherapy for head and neck squamous cell carcinoma Thorsten Fuereder short review Open access 20 June 2016 Pages: 66 - 69
Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer Mathilde FoedermayrMiriam SebestaRupert Bartsch original report 09 May 2016 Pages: 70 - 75
CDK4/6 inhibition in luminal breast cancer Simon Peter GampenriederGabriel RinnerthalerRichard Greil short review Open access 20 June 2016 Pages: 76 - 81
Immune checkpoint blockade in ovarian cancer Lukas WeissFlorian HuemerRichard Greil short review Open access 02 June 2016 Pages: 82 - 84
Endometrial cancer treated with levonorgestrel-releasing intrauterine device for almost three years in an elderly woman with comorbidity Lisbeth Anita AndreasenSofie Leisby AntonsenAnnette Settnes case report 31 May 2016 Pages: 85 - 87
Circulating tumor cells and circulating tumor DNA in colon cancer Mikhail FedyaninElizaveta PolyanskayaSergei Tjulandin short review 10 May 2016 Pages: 88 - 92
Is there room for chemotherapy in elderly patients with metastatic castration-resistant prostate cancer (mCRPC) in the era of targeted hormone therapy? Ercan Müldür comment 02 June 2016 Pages: 93 - 95
Initial emergencies in children and adolescents with malignant hematologic–oncological diseases Andishe AttarbaschiGeorg Mann review 20 May 2016 Pages: 96 - 103